Ascend Health's Q1: Sleep Therapy, Debt Paydown, Growth

Ascend Healths first quarter earnings call revealed a strategic pivot towards home-based care, marked by a $82 million equipment sale and a $52 million gain. Adjusted EBITDA hit $58 million, despite seasonal cash flow dips and cost pressures. The company is doubling down on sleep therapy, with the Sleep Journey program excelling and a Sleep Center of Excellence launching soon. Ascend Health boasts a diversified payor mix and strong compliance, with margins transforming post-divestiture. Theyre resetting their balance sheet, maintaining liquidity, and positioning for growth in sleep and other categories. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b2f61db8b9ab3110